However, a back room deal was quickly cut.
>WASHINGTON — After weeks of talks, drug industry lobbyists were growing nervous. To cut a deal with the White House on overhauling health care, they needed to be sure that President Obama would stop a proposal intended to bring down medicine prices.
On June 3, 2009, one of the lobbyists e-mailed Nancy-Ann DeParle, the president’s health care adviser. Ms. DeParle reassured the lobbyist. Although Mr. Obama was overseas, she wrote, she and other top officials had “made decision, based on how constructive you guys have been, to oppose importation” on a different proposal.
Just like that, Mr. Obama’s staff signaled a willingness to put aside support for the reimportation of prescription medicines at lower prices and by doing so solidified a compact with an industry the president had vilified on the campaign trail.
https://www.nytimes.com/2012/06/09/us/politics/e-mails-revea...
Supposedly, the industry promised to control costs themselves in exchange for the deal, but looking at the data on drug prices, we know they never followed through.
It’s not like ACA or even Medicare covers all Rx...hence Medicare Part D (ie drug coverage) which was done under GW Bush, at the time the GOP distanced themselves and later Obama tried to dismantle Medicare part D, but the dems has to pull him back (politically dems couldn’t gut drug coverage for Medicare patients).
[1]: https://www.bloomberg.com/news/articles/2018-08-07/trump-for...
The US public has been subsidizing pharmaceutical research for the entire world with these inflated prices and hopefully that changes soon.
This is what some people refuse to acknowledge when they mock the US for having such high prices. If US prices drop over night to match RoW pharma companies are not just going to go quietly into that good night, there will be consequences. Most likely, a lowering of US prices will result in a rise everywhere else, so enjoy your low prices while they last. It’s time for Americans to put America first.
https://www.healthaffairs.org/do/10.1377/hblog20170602.06037...